-
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
Atmowihardjo, L., Schippers, J. R., Bartelink, I. H., Bet, P. M., van Rein, N., Purdy, K., Cavalla, D., Comberiati, V., McElroy, A., Snape, S. D., Bogaard, H. J., Heunks, L., Juffermans, N., Schultz, M., Tuinman, P. R., Bos, L. D. J. & Aman, J., Dec 2022, In: Trials. 23, 1, p. 158 158.Research output: Contribution to journal › Article › Academic › peer-review
-
Neurofilament light increases over time in severe COVID-19 and is associated with delirium
Amsterdam UMC Covid-19 Biobank, 26 Jul 2022, In: Brain Communications. 4, 4, fcac195.Research output: Contribution to journal › Article › Academic › peer-review
-
Long-term clinical outcomes of COVID-19 patients treated with imatinib
CounterCOVID Collaborative Group, 1 Apr 2022, In: The Lancet Respiratory Medicine. 10, 4, p. e34-e35Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications